Understanding how pancreatic alpha cells respond to insulin resistance and type 2 diabetes
Pancreatic islet alpha cell response to insulin resistance and type 2 diabetes
This study is looking at how certain cells in the pancreas behave when someone has type 2 diabetes, especially when the body struggles to use insulin properly, and it aims to find new ways to help manage diabetes better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Veterans Health Administration NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10943903 on NIH RePORTER |
What this research studies
This research investigates the role of pancreatic alpha cells in type 2 diabetes (T2D), particularly how they respond to insulin resistance and other metabolic stresses. By examining the molecular mechanisms that regulate alpha cell function, the study aims to uncover critical factors that contribute to the dysregulation of hormone secretion in diabetes. The research focuses on transcription factors, such as MAFB, that are essential for the proper functioning of both alpha and beta cells in the pancreas. Through this work, the researchers hope to identify potential therapeutic targets for improving diabetes management.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with type 2 diabetes, particularly those experiencing insulin resistance.
Not a fit: Patients with type 1 diabetes or those without any form of diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that better regulate blood sugar levels in patients with type 2 diabetes.
How similar studies have performed: Previous research has shown promising results in understanding the role of pancreatic cells in diabetes, suggesting that this approach could yield valuable insights.
Where this research is happening
Nashville, United States
- Veterans Health Administration — Nashville, United States (Active)
Researchers
- Principal investigator: Coate, Kathryn (Katie) Colbert — Veterans Health Administration
- Study coordinator: Coate, Kathryn (Katie) Colbert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.